(S (NP-SBJ (NP Activation/NN) (PP of/IN (NP human/JJ monocytic/JJ cells/NNS)) (PP by/IN (NP-COOD (NP (NP-COOD (NP Treponema/FW pallidum/FW) and/CC (NP Borrelia/FW burgdorferi/FW)) lipoproteins/NNS) and/CC (NP synthetic/JJ lipopeptides/NNS)))) (VP-COOD (VP proceeds/VBZ (PP via/IN (NP (NP a/DT pathway/NN) (ADJP distinct/JJ (PP from/IN (NP (NP that/DT) (PP of/IN (NP lipopolysaccharide/NN)))))))) but/CC (VP involves/VBZ (NP the/DT transcriptional/JJ activator/NN NF-kappa/NN B/NN))) ./.)
(S (NP-SBJ There/EX) (VP is/VBZ (NP-PRD increasing/VBG evidence/NN (SBAR that/IN (S (NP-SBJ (NP lipoproteins/NNS) (PP of/IN (NP-COOD (NP Treponema/FW pallidum/FW) and/CC (NP Borrelia/FW burgdorferi/FW)))) (VP are/VBP (NP-PRD key/JJ inflammatory/JJ mediators/NNS) (PP-TMP during/IN (NP-COOD (NP syphilis/NN) and/CC (NP Lyme/NN disease/NN)))))))) ./.)
(S (NP-SBJ (NP A/DT principal/JJ objective/NN) (PP of/IN (NP the/DT present/JJ study/NN))) (VP was/VBD (S-PRD (NP-SBJ */-NONE-) (VP to/TO (VP identify/VB (ADVP more/RBR precisely/RB) (NP (NP-COOD (NP similarities/NNS) and/CC (NP divergences/NNS)) (PP among/IN (NP (ADJP-COOD (ADJP (NP (NP lipopolysaccharide/NN) (PRN -LRB-/-LRB- (NP LPS/NN) -RRB-/-RRB-) -/:) (ADJP *?*/-NONE-)) and/CC (ADJP lipoprotein-lipopeptide-induced/JJ)) immune/JJ cell/NN signaling/NN events/NNS))))))) ./.)
(S (PP Like/IN (NP LPS/NN)) ,/, (NP-SBJ (NP-COOD (NP purified/VBN native/JJ B./FW burgdorferi/FW OspA/NN) and/CC (NP (NP synthetic/JJ analogs/NNS) (PP of/IN (NP-COOD (NP OspA/NN) ,/, (NP OspB/NN) ,/, and/CC (NP (NP two/CD T./FW pallidum/FW lipoproteins/NNS) (PRN -LRB-/-LRB- (NP-COOD (NP Tpp47/NN) and/CC (NP Tpp17/NN)) -RRB-/-RRB-)))))) (NP all/DT)) (VP induced/VBD (NP (NP NF-kappa/NN B/NN translocation/NN) (PP in/IN (NP THP-1/NN human/JJ monocytoid/NN cells/NNS)))) ./.)
(S (NP-SBJ (NP Acylation/NN) (PP of/IN (NP-COOD (NP OspA/NN) and/CC (NP the/DT synthetic/JJ peptides/NNS)))) (VP was/VBD (ADJP-PRD requisite/JJ (PP for/IN (NP cell/NN activation/NN)))) ./.)
(S (NP-SBJ Polymyxin/NN B/NN) (VP abrogated/VBD (NP (NP only/RB the/DT response/NN) (PP to/TO (NP LPS/NN)))) ./.)
(S (PP By/IN (S (NP-SBJ */-NONE-) (VP using/VBG (NP (NP 70Z\/3-derived/JJ pre-B-cell/NN lines/NNS) (VP (VP-COOD either/CC (VP lacking/VBG (NP *RNR*-32/-NONE-)) or/CC (VP expressing/VBG (NP *RNR*-32/-NONE-))) (NP-32 (NP human/JJ CD14/NN) (PRN -LRB-/-LRB- (NP the/DT LPS/NN receptor/NN) -RRB-/-RRB-))))))) ,/, (NP-SBJ it/PRP) (VP was/VBD (VP observed/VBN (SBAR that/IN (S (NP-SBJ (NP expression/NN) (PP of/IN (NP human/JJ CD14/NN))) (VP imparted/VBD (NP (NP responsiveness/NN) (PP-COOD (PP to/TO (NP LPS/NN)) but/CC (PP not/RB to/TO (NP-COOD (NP OspA/NN) or/CC (NP spirochetal/JJ lipopeptides/NNS))))) (PRN -LRB-/-LRB- (S (NP-SBJ-100 */-NONE-) (VP assessed/VBN (NP *-100/-NONE-) (PP by/IN (NP-COOD (NP (NP induction/NN) (PP of/IN (NP NF-kappa/NN B/NN))) and/CC (NP (NP expression/NN) (PP of/IN (NP surface/NN immunoglobulin/NN M/NN))))))) -RRB-/-RRB-)))))) ./.)
(S (S (ADVP-TMP Finally/RB) ,/, (NP-SBJ-33 (NP the/DT biological/JJ relevance/NN) (PP of/IN (NP the/DT observation/NN (SBAR that/IN (S (NP-SBJ T./FW pallidum/FW lipoproteins-lipopeptides/NNS) (VP induce/VBP (NP (NP (NP-COOD both/CC (NP NF-kappa/NN B/NN) and/CC (NP cytokine/NN)) production/NN) (PP in/IN (NP monocytes/NNS))))))))) (VP was/VBD (VP supported/VBN (NP *-33/-NONE-) (PP by/IN (NP-LGS (NP the/DT ability/NN (S *ICH*-34/-NONE-)) (PP of/IN (NP the/DT synthetic/JJ analogs/NNS)) (S-34 (NP-SBJ */-NONE-) (VP to/TO (VP promote/VB (NP human/JJ immunodeficiency/NN virus/NN replication/NN) (PP in/IN (NP (ADJP chronically/RB infected/JJ) U1/NN monocytoid/NN cells/NNS))))))))) ;/:) (S (NP-SBJ these/DT observations/NNS) (ADVP also/RB) (VP suggest/VBP (NP (NP a/DT potential/JJ mechanism/NN) (SBAR (WHADVP-35 whereby/WRB) (S (NP-SBJ a/DT syphilitic/JJ chancre/NN) (VP can/MD (VP serve/VB (PP as/IN (NP (NP a/DT cofactor/NN) (PP for/IN (NP human/JJ immunodeficiency/NN virus/NN transmission/NN)))) (ADVP *T*-35/-NONE-))))))) ./.))
(S (NP-SBJ The/DT combined/JJ data/NNS) (VP lend/VBP (NP additional/JJ support/NN) (PP to/TO (NP the/DT proposal/NN (SBAR-COOD (SBAR that/IN (S (NP-SBJ-COOD (NP spirochetal/JJ lipoproteins/NNS) and/CC (NP LPS/NN)) (VP initiate/VBP (NP monocyte/NN activation/NN) (PP via/IN (NP different/JJ cell/NN surface/NN events/NNS))))) but/CC (SBAR that/IN (S (NP-SBJ-36 the/DT signaling/NN pathways/NNS) (ADVP ultimately/RB) (VP converge/VBP (S (NP-SBJ *-36/-NONE-) (VP to/TO (VP produce/VB (NP (ADJP qualitatively/RB similar/JJ) cellular/JJ responses/NNS))))))))))) ./.)
